Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues
Literature
Read More
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
Press Release
Read More
NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder
Press Release
Read More
NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
Press Release
Read More
Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx™ Hyperplexed Immuno-Assay in Hodgkin Lymphoma
Literature
Read More